Searle & Co.
- SEC CIK
- 0000710127
- Latest filing
- Jul 27, 2026
TAK holding history
Takeda Pharmaceutical Co Ltd in every 13F filed by Searle & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TAK overviewAll 13F holders of TAKFull Q2 2026 holdings
- Shares (Q2 2022)
- 0
- Sold out in Q2 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2022 | 0 | $0 | 0.0% | −31,697−100.0% | Sold out | Holders |
| Q1 2022 | 31,697 | $454.0K | 0.2% | −70−0.2% | Reduced | Holders |
| Q4 2021 | 31,767 | $433.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2021 | 31,767 | $520.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2021 | 31,767 | $535.0K | 0.2% | −1,641−4.9% | Reduced | Holders |
| Q1 2021 | 33,408 | $610.0K | 0.3% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.